Zimmer Biomet Price To Earning vs. Cash And Equivalents

ZBH Stock  USD 110.62  0.12  0.11%   
Based on Zimmer Biomet's profitability indicators, Zimmer Biomet Holdings is yielding more profit at this time then in previous quarter. It has a moderate probability of reporting better profitability numbers in January. Profitability indicators assess Zimmer Biomet's ability to earn profits and add value for shareholders. As of now, Zimmer Biomet's Price Sales Ratio is increasing as compared to previous years. As of now, Zimmer Biomet's Net Income Per Share is increasing as compared to previous years.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.80.7182
Moderately Up
Pretty Stable
Operating Profit Margin0.220.1728
Significantly Up
Slightly volatile
For Zimmer Biomet profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Zimmer Biomet to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Zimmer Biomet Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Zimmer Biomet's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Zimmer Biomet Holdings over time as well as its relative position and ranking within its peers.
  

Zimmer Biomet's Revenue Breakdown by Earning Segment

Check out Your Current Watchlist.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.597
Dividend Share
0.96
Earnings Share
5.24
Revenue Per Share
37.006
Quarterly Revenue Growth
0.04
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Zimmer Biomet Holdings Cash And Equivalents vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Zimmer Biomet's current stock value. Our valuation model uses many indicators to compare Zimmer Biomet value to that of its competitors to determine the firm's financial worth.
Zimmer Biomet Holdings is rated first in price to earning category among its peers. It is rated fourth in cash and equivalents category among its peers creating about  4,853,378  of Cash And Equivalents per Price To Earning. As of now, Zimmer Biomet's Cash And Equivalents is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zimmer Biomet's earnings, one of the primary drivers of an investment's value.

Zimmer Biomet's Earnings Breakdown by Geography

Zimmer Cash And Equivalents vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Zimmer Biomet

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
77.41 X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.

Zimmer Biomet

Cash

 = 

Bank Deposits

+

Liquidities

 = 
375.7 M
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).

Zimmer Cash And Equivalents Comparison

Zimmer Biomet is currently under evaluation in cash and equivalents category among its peers.

Zimmer Biomet Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Zimmer Biomet, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Zimmer Biomet will eventually generate negative long term returns. The profitability progress is the general direction of Zimmer Biomet's change in net profit over the period of time. It can combine multiple indicators of Zimmer Biomet, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-191 M-181.4 M
Operating Income1.3 B853 M
Income Before Tax1.1 B1.1 B
Net IncomeB585 M
Income Tax Expense42.2 M66.9 M
Net Income Applicable To Common Shares266.1 M252.8 M
Total Other Income Expense Net-210.4 M-220.9 M
Net Income From Continuing Ops475.2 M445.5 M
Non Operating Income Net Other-115.2 M-109.4 M
Interest Income189.5 M148.5 M
Net Interest Income-193.5 M-203.2 M
Change To Netincome435.3 M457 M
Net Income Per Share 4.91  5.15 
Income Quality 1.54  1.38 
Net Income Per E B T 0.96  0.81 

Zimmer Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Zimmer Biomet. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Zimmer Biomet position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Zimmer Biomet's important profitability drivers and their relationship over time.

Use Zimmer Biomet in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Zimmer Biomet position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zimmer Biomet will appreciate offsetting losses from the drop in the long position's value.

Zimmer Biomet Pair Trading

Zimmer Biomet Holdings Pair Trading Analysis

The ability to find closely correlated positions to Zimmer Biomet could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Zimmer Biomet when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Zimmer Biomet - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Zimmer Biomet Holdings to buy it.
The correlation of Zimmer Biomet is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Zimmer Biomet moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Zimmer Biomet Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Zimmer Biomet can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Zimmer Biomet position

In addition to having Zimmer Biomet in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Health Care ETFs Thematic Idea Now

Health Care ETFs
Health Care ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out Your Current Watchlist.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
To fully project Zimmer Biomet's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Zimmer Biomet Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Zimmer Biomet's income statement, its balance sheet, and the statement of cash flows.
Potential Zimmer Biomet investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Zimmer Biomet investors may work on each financial statement separately, they are all related. The changes in Zimmer Biomet's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zimmer Biomet's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.